Current Approach to Treatment of Non-small Cell Lung Cancer in Developing Countries—Time for a Rethink?
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference5 articles.
1. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer;Scagliotti;J Clin Oncol,2008
2. Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer;Park;J Clin Oncol,2007
3. Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2;Lilenbaum;J Clin Oncol,2008
4. Maintenance pemetrexed plus best supportive care (BSC) versus placebo plus BSC: a phase III study;Ciuleanu;J Clin Oncol,2008
5. Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis;Ardizzoni;J Natl Cancer Inst,2007
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rationale and Design of PEMVITASTART—An Open-label Randomized Trial Comparing Simultaneous Versus Standard Initiation of Vitamin B 12 and Folate Supplementation in Nonsquamous, Non–Small-cell Lung Cancer Patients Undergoing First-line Pemetrexed-based Chemotherapy;Clinical Lung Cancer;2017-07
2. ALK gene rearranged lung adenocarcinomas: molecular genetics and morphology in cohort of patients from North India;APMIS;2016-08-08
3. Chemotherapy regimens for metastatic nonsmall cell lung cancer: Generating good quality data is important before challenging evidence;Lung India;2016
4. Palliation in metastatic non-small cell lung cancer: Early integration with standard oncological care is the key;Lung India;2014
5. Management of advanced lung cancer in resource-constrained settings: a perspective from India;Expert Review of Anticancer Therapy;2012-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3